SU1240038A1 - 3-hydroxyestra-1,3,5-triene-17-hydrazone showing hormonal and antitumor activity - Google Patents

3-hydroxyestra-1,3,5-triene-17-hydrazone showing hormonal and antitumor activity

Info

Publication number
SU1240038A1
SU1240038A1 SU3835917/04A SU3835917A SU1240038A1 SU 1240038 A1 SU1240038 A1 SU 1240038A1 SU 3835917/04 A SU3835917/04 A SU 3835917/04A SU 3835917 A SU3835917 A SU 3835917A SU 1240038 A1 SU1240038 A1 SU 1240038A1
Authority
SU
USSR - Soviet Union
Prior art keywords
triene
hydrazone
antitumor activity
hydroxyestra
hormonal
Prior art date
Application number
SU3835917/04A
Other languages
Russian (ru)
Inventor
Е.А. Штокарева
В.И. Нифонтов
Н.Д. Лагова
З.П. Софьина
В.И. Киселев
З.С. Смирнова
А.Б. Сыркин
П.В. Лопатин
О.И. Коняева
Л.Н. Воловельский
В.В. Натаров
И.А. Растрепина
Original Assignee
Уральский политехнический институт им.С.М.Кирова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Уральский политехнический институт им.С.М.Кирова filed Critical Уральский политехнический институт им.С.М.Кирова
Priority to SU3835917/04A priority Critical patent/SU1240038A1/en
Application granted granted Critical
Publication of SU1240038A1 publication Critical patent/SU1240038A1/en

Links

Landscapes

  • Steroid Compounds (AREA)

Abstract

FIELD: organic chemistry, steroids. SUBSTANCE: product: 3-hydroxy-1,3,5-triene-17-hydrazone of the formulashowing hormonal and antitumor activity. EFFECT: improved method of synthesis.
SU3835917/04A 1984-11-23 1984-11-23 3-hydroxyestra-1,3,5-triene-17-hydrazone showing hormonal and antitumor activity SU1240038A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU3835917/04A SU1240038A1 (en) 1984-11-23 1984-11-23 3-hydroxyestra-1,3,5-triene-17-hydrazone showing hormonal and antitumor activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU3835917/04A SU1240038A1 (en) 1984-11-23 1984-11-23 3-hydroxyestra-1,3,5-triene-17-hydrazone showing hormonal and antitumor activity

Publications (1)

Publication Number Publication Date
SU1240038A1 true SU1240038A1 (en) 1996-10-27

Family

ID=60539628

Family Applications (1)

Application Number Title Priority Date Filing Date
SU3835917/04A SU1240038A1 (en) 1984-11-23 1984-11-23 3-hydroxyestra-1,3,5-triene-17-hydrazone showing hormonal and antitumor activity

Country Status (1)

Country Link
SU (1) SU1240038A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6723858B2 (en) 1993-08-06 2004-04-20 The Children's Medical Center Corporation Estrogenic compounds as anti-mitotic agents
US6995278B2 (en) 2000-08-18 2006-02-07 Entre Med, Inc. Antiangiogenic agents
US7012070B2 (en) 1993-08-06 2006-03-14 The Children's Medical Center Corporation Estrogenic compounds as anti-mitotic agents
US7087592B1 (en) 1999-08-23 2006-08-08 Entre Med, Inc. Compositions comprising purified 2-methoxyestradiol and methods of producing same
US7135581B2 (en) 2000-08-18 2006-11-14 Entremed, Inc. Antiangiogenic agents

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6723858B2 (en) 1993-08-06 2004-04-20 The Children's Medical Center Corporation Estrogenic compounds as anti-mitotic agents
US6908910B2 (en) 1993-08-06 2005-06-21 The Children's Medical Center Corporation Estrogenic compounds as anti-mitotic agents
US6930128B2 (en) 1993-08-06 2005-08-16 The Children's Medical Center Corporation Estrogenic compounds as anti-mitotic agents
US7012070B2 (en) 1993-08-06 2006-03-14 The Children's Medical Center Corporation Estrogenic compounds as anti-mitotic agents
US7081477B2 (en) 1993-08-06 2006-07-25 The Children's Medical Center Corporation Estrogenic compounds as anti-mitotic agents
US7381848B2 (en) 1993-08-06 2008-06-03 The Children's Medical Center Corporation Estrogenic compounds as anti-mitotic agents
US7087592B1 (en) 1999-08-23 2006-08-08 Entre Med, Inc. Compositions comprising purified 2-methoxyestradiol and methods of producing same
US7235540B2 (en) 1999-08-23 2007-06-26 Entremed, Inc. Methods of using 2-methoxyestradiol of high purity
US6995278B2 (en) 2000-08-18 2006-02-07 Entre Med, Inc. Antiangiogenic agents
US7135581B2 (en) 2000-08-18 2006-11-14 Entremed, Inc. Antiangiogenic agents

Similar Documents

Publication Publication Date Title
GR3007225T3 (en)
ES8600737A1 (en) Sulfonium compounds, processes for preparing the compounds and pharmacological composiitons containing the same
NO862753L (en) PROCEDURE FOR THE PREPARATION OF ANDOSTA-1,4-DIENE-3,17-DIONE.
ZA83224B (en) New-6-substituted-s-triazolo(3,4-a)phtalazine derivatives
MY103189A (en) Nor-statine and nor-cyclostatine polypeptides
HUT37410A (en) Process for the production of benzothiazole- and benzothiophene-derivatives, as well as of therapeutic preparations containing them as agent
DE3571982D1 (en) Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds
AU567613B2 (en) Method for treatment of neoplasms.
DE3665721D1 (en) New process for the preparation of certain steroids, especially intermediates for the preparation of proligestone and related compounds, and new intermediates formed in this process
ZA795478B (en) Process for the preparation of cis-(+)-3,4-dihydro-n,n2-trimethyl-2h-1-benzopyran-3-amine and intermediates produced thereby
SU1240038A1 (en) 3-hydroxyestra-1,3,5-triene-17-hydrazone showing hormonal and antitumor activity
DK0719276T3 (en) Estradiol esters with strong oral action as well as pharmaceutical preparations containing them
IE860227L (en) Monoclonal anti-alpha-amylase antibody
HUT46077A (en) Process for the microbiological production of 9alpha-hydroxy-4-androsten-3,17-dione
GB2155018B (en) 2x-cyano-4d,5x-epoxy-androstane -3,17-dione
DE3462257D1 (en) 4-amino-3-imidozolin-2-on and (2-methoxy-2-imino-ethyl) urea, their preparation and application
DE3561324D1 (en) Process for the manufacture of metallic diphthalocyanines, the obtained products and their use as electroactive agents
CS240886A2 (en) Method of 1-methyl-1, 4-androstadiene-3, 17-dione production
EP0119546A3 (en) Process for the preparation of compounds of the 4-oxo-damascon series, and perfumes of this compound class
IE873394L (en) Material for treatment of ammonia.
EP0599658A3 (en) Process for production of 6beta, 14alpha-dihydroxy-4-androstene-3, 17-dione.
IT1158018B (en) FERMENTATION PROCEDURE FOR THE PRODUCTION OF 6-FLUORO-9-ALFAIDROSSI-ANDROST-4-ENE-3,17-DIONE, USEFUL IN PARTICULAR FOR THE PRODUCTION OF STEROIDS, AND PRODUCT OBTAINED
SU1259652A1 (en) 5-ethoxy-2-ethylthiobenzimidazole hydrochloride showing antihypoxyc and stress-protecting activity
SU968995A1 (en) Dialkylammonium benzylarsonates showing antibacterial and fungicide activity
SU1018374A1 (en) S-[2-(1-adamantylcarboxamido)ethyl]isothiuronium bromide showing antiarrhythmic activity